Skip to main content
Top
Published in: BMC Gastroenterology 1/2012

Open Access 01-12-2012 | Research article

Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection

Published in: BMC Gastroenterology | Issue 1/2012

Login to get access

Abstract

Background

Many studies suggest that in chronic hepatitis B virus (HBV) infection regulate T (Treg) cells and interlukin-17-producing T help cells (Th17) are mutually antagonistic in the immune response. This study is aimed to reveal the cell differentiation environment and the significance of Treg and Th17 balance in the development of acute and chronic HBV infection.

Methods

Ten patients with acute HBV infection (AHB) and forty-eight patients with chronic HBV infection, including 12 asymptomatic HBV carriers (HBV carriers), 18 chronic hepatitis B patients (CHB) and 18 acute-on-chronic HBV-related liver failure (ACHBLF) were enrolled. Treg and Th17 cells differentiation related cytokine levels were detected by using ELISA. Flow cytometry was employed to count the Treg and Th17 frequency in peripheral blood.

Results

Compared to health controls both AHB and ACHBLF patients favoured Th17 cell differentiation, accompanied by a higher proportion of peripheral Th17 cells (P < 0.01) and high level of interleukin-17A (IL-17A) (P < 0.01). However, asymptomatic HBV carriers and CHB were conducive to Treg cell differentiation. In AHB and ACHBLF, peripheral blood IL-17A + CD4 + T cell frequency increased significantly compared with healthy controls. Changes of Treg and Th17 cell frequency were not completely consistent. Both CHB and ACHBLF had lower level of Treg/Th17 ratio than in health control (P < 0.05). Both plasm IL-17A levels (r = −0.72, p<0.001) and Th17 frequency(r = −0.49, p = 0.0003) negatively correlated with plasma HBV DNA load in patients with chronic HBV infection. In addition, both Th17 frequency and plasm IL-17A levels positively correlated with ALT (r = 0.33,p = 0.01 Vs r = 0.29,p = 0.04) and total bilirubin levels (r = 0.72,p<0.0001 Vs r = 0.53,p = 0.0001) in these chronic HBV-infected subjects. However, for AHB there were positive correlation between both Th17 frequency (r = 0.64, p = 0.04) and plasm IL-17A levels (r = 0.69, p = 0.02) with serum ALT levels, but no significant correlation between both HBV DNA level and total bilirubin level with Th17 frequency or plasm IL-17A levels were found. Furthermore, Treg/Th17 ratio was negatively correlated with total bilirubin levels (r = −0.41, p = 0.004) in chronic HBV-infected patients, especially in patients with ACHBLF (r = −0.69,p = 0.001) and positively correlated with viral load in these chronic HBV-infected subjects (r = 0.55, p<0.0001).

Conclusions

Th17 cells are involved in acute and chronic HBV infection, especially in AHB and ACHBLF. CHB and ACHBLF patients manifested obvious Treg/Th17 ratio imbalance, which might be linked to disease progression and the continuous HBV infection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ganem D, Prince AM: Hepatitis B virus infection—natural history and clinical consequences. N Engl J Med. 2004, 350: 1118-1129. 10.1056/NEJMra031087.CrossRefPubMed Ganem D, Prince AM: Hepatitis B virus infection—natural history and clinical consequences. N Engl J Med. 2004, 350: 1118-1129. 10.1056/NEJMra031087.CrossRefPubMed
2.
go back to reference Kao JH, Chen DS: Global control of hepatitis B virus infection. Lancet Infect Dis. 2002, 2: 395-403. 10.1016/S1473-3099(02)00315-8.CrossRefPubMed Kao JH, Chen DS: Global control of hepatitis B virus infection. Lancet Infect Dis. 2002, 2: 395-403. 10.1016/S1473-3099(02)00315-8.CrossRefPubMed
3.
go back to reference Bertoletti A, Maini M, Williams R: Role of hepatitis B virus specific cytotoxic T cells in liver damage and viral control. Antiviral Res. 2003, 60: 61-66. 10.1016/j.antiviral.2003.08.012.CrossRefPubMed Bertoletti A, Maini M, Williams R: Role of hepatitis B virus specific cytotoxic T cells in liver damage and viral control. Antiviral Res. 2003, 60: 61-66. 10.1016/j.antiviral.2003.08.012.CrossRefPubMed
4.
go back to reference Lohse AW, Weiler-Normann C, Tiegs G: Immune-mediated liver injury. J Hepatol. 2010, 52: 136-144. 10.1016/j.jhep.2009.10.016.CrossRefPubMed Lohse AW, Weiler-Normann C, Tiegs G: Immune-mediated liver injury. J Hepatol. 2010, 52: 136-144. 10.1016/j.jhep.2009.10.016.CrossRefPubMed
5.
go back to reference Jung MC, Gerd RP: Immunology of hepatitis B infection. Lancet Infect Dis. 2001, 2: 43-50.CrossRef Jung MC, Gerd RP: Immunology of hepatitis B infection. Lancet Infect Dis. 2001, 2: 43-50.CrossRef
6.
go back to reference Wang FS: Clinical immune characterization of hepatitis B virus infection and implications for immune intervention: progress and challenges. Hepatol Res. 2007, 37: S339-S346. 10.1111/j.1872-034X.2007.00222.x.CrossRefPubMed Wang FS: Clinical immune characterization of hepatitis B virus infection and implications for immune intervention: progress and challenges. Hepatol Res. 2007, 37: S339-S346. 10.1111/j.1872-034X.2007.00222.x.CrossRefPubMed
7.
go back to reference Beacher-Allan C, Brown JA, Freeman GJ, Hafler DA: CD4+CD25high regulatory cells in human peripheral blood. J Immunol. 2001, 167: 1245-1253.CrossRef Beacher-Allan C, Brown JA, Freeman GJ, Hafler DA: CD4+CD25high regulatory cells in human peripheral blood. J Immunol. 2001, 167: 1245-1253.CrossRef
8.
go back to reference Sakaguchi S: Naturally arising CD4 + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immuno. 2004, 22: 531-562. 10.1146/annurev.immunol.21.120601.141122.CrossRef Sakaguchi S: Naturally arising CD4 + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immuno. 2004, 22: 531-562. 10.1146/annurev.immunol.21.120601.141122.CrossRef
9.
go back to reference Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T: FoxP3 + CD25 + CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006, 212: 8-27. 10.1111/j.0105-2896.2006.00427.x.CrossRefPubMed Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T: FoxP3 + CD25 + CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006, 212: 8-27. 10.1111/j.0105-2896.2006.00427.x.CrossRefPubMed
10.
go back to reference Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ, Kusters JG, Janssen HL: Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology. 2005, 41 (4): 771-778. 10.1002/hep.20649.CrossRefPubMed Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ, Kusters JG, Janssen HL: Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology. 2005, 41 (4): 771-778. 10.1002/hep.20649.CrossRefPubMed
11.
go back to reference Peng G, Li S, Wu W, Sun Z, Chen Y, Chen Z: Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology. 2008, 123 (1): 57-65. 10.1111/j.1365-2567.2007.02691.x.CrossRefPubMedPubMedCentral Peng G, Li S, Wu W, Sun Z, Chen Y, Chen Z: Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection. Immunology. 2008, 123 (1): 57-65. 10.1111/j.1365-2567.2007.02691.x.CrossRefPubMedPubMedCentral
12.
go back to reference Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z, Zhao JM, Zhang B, Shi M, Ding X, Tang Z, Fu YX, Wang FS: Circulating and liver resident CD4 + CD25 + regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol. 2006, 177 (1): 739-747.CrossRefPubMed Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z, Zhao JM, Zhang B, Shi M, Ding X, Tang Z, Fu YX, Wang FS: Circulating and liver resident CD4 + CD25 + regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol. 2006, 177 (1): 739-747.CrossRefPubMed
13.
go back to reference O'Quinn DB, Palmer MT, Lee YM, Weaver CT: Emergence of the Th17 pathway and its role in host defense. Adv Immunol. 2008, 99: 115-163.CrossRefPubMed O'Quinn DB, Palmer MT, Lee YM, Weaver CT: Emergence of the Th17 pathway and its role in host defense. Adv Immunol. 2008, 99: 115-163.CrossRefPubMed
14.
go back to reference Sieve AN, Meeks KD, Bodhankar S, Lee S, Kolls JK, Simecka JW, Berg RE: A novel IL-17-dependent mechanism of cross protection: respiratory infection with mycoplasma protects against a secondary listeria infection. Eur J Immunol. 2009, 39: 426-438. 10.1002/eji.200838726.CrossRefPubMedPubMedCentral Sieve AN, Meeks KD, Bodhankar S, Lee S, Kolls JK, Simecka JW, Berg RE: A novel IL-17-dependent mechanism of cross protection: respiratory infection with mycoplasma protects against a secondary listeria infection. Eur J Immunol. 2009, 39: 426-438. 10.1002/eji.200838726.CrossRefPubMedPubMedCentral
15.
go back to reference Zhang JY, Zhang Z, Lin F, Zou ZS, Xu RN, Jin L, Fu JL, Shi F, Shi M, Wang HF, Wang FS: Interleukin-17-producing CD4 + T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology. 2010, 51: 81-91. 10.1002/hep.23273.CrossRefPubMed Zhang JY, Zhang Z, Lin F, Zou ZS, Xu RN, Jin L, Fu JL, Shi F, Shi M, Wang HF, Wang FS: Interleukin-17-producing CD4 + T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology. 2010, 51: 81-91. 10.1002/hep.23273.CrossRefPubMed
16.
go back to reference Wu W, Li J, Chen F, Zhu H, Peng G, Chen Z: Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients. J Gastroenterol Hepatol. 2010, 25 (4): 750-757. 10.1111/j.1440-1746.2009.06154.x.CrossRefPubMed Wu W, Li J, Chen F, Zhu H, Peng G, Chen Z: Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients. J Gastroenterol Hepatol. 2010, 25 (4): 750-757. 10.1111/j.1440-1746.2009.06154.x.CrossRefPubMed
17.
go back to reference Ye Y, Xie X, Yu J, Zhou L, Xie H, Jiang G, Yu X, Zhang W, Wu J, Zheng S: Involvement of Th17 and Th1 effector responses in patients with Hepatitis B. J Clin Immunol. 2010, 30 (4): 546-555. 10.1007/s10875-010-9416-3.CrossRefPubMed Ye Y, Xie X, Yu J, Zhou L, Xie H, Jiang G, Yu X, Zhang W, Wu J, Zheng S: Involvement of Th17 and Th1 effector responses in patients with Hepatitis B. J Clin Immunol. 2010, 30 (4): 546-555. 10.1007/s10875-010-9416-3.CrossRefPubMed
18.
go back to reference Ge J, Wang K, Meng QH, Qi ZX, Meng FL, Fan YC: Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. J Clin Immunol. 2010, 30 (1): 60-67. 10.1007/s10875-009-9328-2.CrossRefPubMed Ge J, Wang K, Meng QH, Qi ZX, Meng FL, Fan YC: Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. J Clin Immunol. 2010, 30 (1): 60-67. 10.1007/s10875-009-9328-2.CrossRefPubMed
19.
go back to reference Manigold T, Racanelli V: T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infect Dis. 2007, 7: 804-813. 10.1016/S1473-3099(07)70289-X.CrossRefPubMed Manigold T, Racanelli V: T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infect Dis. 2007, 7: 804-813. 10.1016/S1473-3099(07)70289-X.CrossRefPubMed
20.
go back to reference Zhang J-Y, Song C-H, Shi F, Zhang Z, Fu J-L, Wand F-S: Decreased Ratio of Treg Cells to Th17 Cells Correlates with HBV DNA Suppression in Chronic Hepatitis B Patients Undergoing Entecavir Treatment. PLoS One. 2010, 5 (11): e13869-10.1371/journal.pone.0013869.CrossRefPubMedPubMedCentral Zhang J-Y, Song C-H, Shi F, Zhang Z, Fu J-L, Wand F-S: Decreased Ratio of Treg Cells to Th17 Cells Correlates with HBV DNA Suppression in Chronic Hepatitis B Patients Undergoing Entecavir Treatment. PLoS One. 2010, 5 (11): e13869-10.1371/journal.pone.0013869.CrossRefPubMedPubMedCentral
21.
go back to reference Zhai S, Zhang L, Dang S, Yu Y, Zhao Z, Zhao W, Liu L: The ratio of Th-17 to Treg cells is associated with survival of patients with acute-on-chronic hepatitis B liver failure. Viral Immunol. 2011, 24 (4): 303-310. 10.1089/vim.2010.0135.CrossRefPubMed Zhai S, Zhang L, Dang S, Yu Y, Zhao Z, Zhao W, Liu L: The ratio of Th-17 to Treg cells is associated with survival of patients with acute-on-chronic hepatitis B liver failure. Viral Immunol. 2011, 24 (4): 303-310. 10.1089/vim.2010.0135.CrossRefPubMed
22.
go back to reference Lee YK, Mukasa R, Hatton RD, Weaver CT: Developmental plasticity of Th17 and Treg cells. Curr Opin Immunol. 2009, 21: 274-280. 10.1016/j.coi.2009.05.021.CrossRefPubMed Lee YK, Mukasa R, Hatton RD, Weaver CT: Developmental plasticity of Th17 and Treg cells. Curr Opin Immunol. 2009, 21: 274-280. 10.1016/j.coi.2009.05.021.CrossRefPubMed
23.
go back to reference Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006, 441 (7090): 235-238. 10.1038/nature04753.CrossRefPubMed Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006, 441 (7090): 235-238. 10.1038/nature04753.CrossRefPubMed
24.
go back to reference Bouchliou I, Miltiades P, Nakou E, Spanoudakis E, Goutzouvelidis A, Vakalopoulou S, Garypidou V, Kotoula V, Bourikas G, Tsatalas C, Kotsianidis I: Th17 and Foxp3 + T regulatory cell dynamics and distribution in Myelodysplastic syndromes. Clinical Immunol. 2011, 139: 350-359. 10.1016/j.clim.2011.03.001.CrossRef Bouchliou I, Miltiades P, Nakou E, Spanoudakis E, Goutzouvelidis A, Vakalopoulou S, Garypidou V, Kotoula V, Bourikas G, Tsatalas C, Kotsianidis I: Th17 and Foxp3 + T regulatory cell dynamics and distribution in Myelodysplastic syndromes. Clinical Immunol. 2011, 139: 350-359. 10.1016/j.clim.2011.03.001.CrossRef
25.
go back to reference Wang Q, Zheng Y, Huang Z, Tian Y, Zhou J, Mao Q, Wu Y, Ni B: Activated IL-23/IL-17 pathway closely correlates with increased Foxp3 expression in livers of chronic hepatitis B patients. BMC Immunol. 2011, 12: 25-10.1186/1471-2172-12-25.CrossRefPubMedPubMedCentral Wang Q, Zheng Y, Huang Z, Tian Y, Zhou J, Mao Q, Wu Y, Ni B: Activated IL-23/IL-17 pathway closely correlates with increased Foxp3 expression in livers of chronic hepatitis B patients. BMC Immunol. 2011, 12: 25-10.1186/1471-2172-12-25.CrossRefPubMedPubMedCentral
27.
go back to reference Weaver CT, Hatton RD: Interplay between the Th17 and Treg cell lineages: a (co-)evolutionary perspective. Nat Rev Immunol. 2009, 9: 883-889. 10.1038/nri2660.CrossRefPubMed Weaver CT, Hatton RD: Interplay between the Th17 and Treg cell lineages: a (co-)evolutionary perspective. Nat Rev Immunol. 2009, 9: 883-889. 10.1038/nri2660.CrossRefPubMed
28.
go back to reference Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY, Ziegler SF, Littman DR: TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature. 2008, 453: 236-240. 10.1038/nature06878.CrossRefPubMedPubMedCentral Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY, Ziegler SF, Littman DR: TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature. 2008, 453: 236-240. 10.1038/nature06878.CrossRefPubMedPubMedCentral
29.
go back to reference Zhang F, Yao S, Yuan J, Zhang M, He Q, Yang G, Gao Z, Liu H, Chen X, Zhou B: Elevated IL-6 receptor expression on CD4+ T cells contributes to the increased Th17 responses in patients with chronic hepatitis B. Virol J. 2011, 8: 270-275. 10.1186/1743-422X-8-270.CrossRefPubMedPubMedCentral Zhang F, Yao S, Yuan J, Zhang M, He Q, Yang G, Gao Z, Liu H, Chen X, Zhou B: Elevated IL-6 receptor expression on CD4+ T cells contributes to the increased Th17 responses in patients with chronic hepatitis B. Virol J. 2011, 8: 270-275. 10.1186/1743-422X-8-270.CrossRefPubMedPubMedCentral
30.
go back to reference Li N, Bian H, Zhang J, Li X, Ji X, Zhang Y: The Th17/Treg imbalance exists in patients with heart failure with normal ejection fraction and heart failure with reduced ejection fraction. Clin Chim Acta. 2010, 411: 1963-1968. 10.1016/j.cca.2010.08.013.CrossRefPubMed Li N, Bian H, Zhang J, Li X, Ji X, Zhang Y: The Th17/Treg imbalance exists in patients with heart failure with normal ejection fraction and heart failure with reduced ejection fraction. Clin Chim Acta. 2010, 411: 1963-1968. 10.1016/j.cca.2010.08.013.CrossRefPubMed
31.
go back to reference Li J, Wang L, Wang S, Zhu H, Ye P, Xie A, Shen B, Liu C, Guo C, Fu Q, Zhang K, Xia J: The Treg/Th17 imbalance in patients with idiopathic dilated cardiomyopathy. Scand J Immunol. 2010, 71: 298-303. 10.1111/j.1365-3083.2010.02374.x.CrossRefPubMed Li J, Wang L, Wang S, Zhu H, Ye P, Xie A, Shen B, Liu C, Guo C, Fu Q, Zhang K, Xia J: The Treg/Th17 imbalance in patients with idiopathic dilated cardiomyopathy. Scand J Immunol. 2010, 71: 298-303. 10.1111/j.1365-3083.2010.02374.x.CrossRefPubMed
32.
go back to reference Niu Y, Liu H, Yin D, Yi R, Chen T, Xue H, Zhang S, Lin S, Zhao Y: The balance between intrahepatic IL-17 + T cells and Foxp3+ regulatory T cells plays an important role in HBV-related end-stage liver disease. BMC Immunol. 2011, 12: 47-55. 10.1186/1471-2172-12-47.CrossRefPubMedPubMedCentral Niu Y, Liu H, Yin D, Yi R, Chen T, Xue H, Zhang S, Lin S, Zhao Y: The balance between intrahepatic IL-17 + T cells and Foxp3+ regulatory T cells plays an important role in HBV-related end-stage liver disease. BMC Immunol. 2011, 12: 47-55. 10.1186/1471-2172-12-47.CrossRefPubMedPubMedCentral
Metadata
Title
Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection
Publication date
01-12-2012
Published in
BMC Gastroenterology / Issue 1/2012
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-12-43

Other articles of this Issue 1/2012

BMC Gastroenterology 1/2012 Go to the issue